Primary completion· ClinicalTrials.gov
A Study of XW003 Injection in Chinese Adolescents With Obesity
Oral ecnoglutide tablet History and Updates
34 events · 2021 – present
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
0
FDA Approvals
0
Label Revisions
34
Trial Milestones
0
Pivotal Publications
Source: openFDA, ClinicalTrials.gov via AACT, PubMed · Hipa.ai, 2026-05-21Download chart as PNG
This page tracks every FDA action, clinical trial milestone, and major publication for Oral ecnoglutide tablet since 2021, drawn from openFDA, ClinicalTrials.gov, and PubMed.
Upcoming & expected milestones
Primary completion· ClinicalTrials.gov
A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Part
Primary completion· ClinicalTrials.gov
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
Primary completion· ClinicalTrials.gov
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
Primary completion· ClinicalTrials.gov
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy
Past events
2026
Primary completion· ClinicalTrials.gov
A Study of XW003 Injection in Chinese Adolescents With Obesity
Trial started· ClinicalTrials.gov
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy
Trial registered· ClinicalTrials.gov
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy
Trial started· ClinicalTrials.gov
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
Trial registered· ClinicalTrials.gov
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
2025
Trial registered· ClinicalTrials.gov
A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Part
Trial started· ClinicalTrials.gov
A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Part
Trial registered· ClinicalTrials.gov
A Study of XW003 Injection in Chinese Adolescents With Obesity
Trial started· ClinicalTrials.gov
A Study of XW003 Injection in Chinese Adolescents With Obesity
Trial started· ClinicalTrials.gov
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
Trial registered· ClinicalTrials.gov
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
2024
Primary completion· ClinicalTrials.gov
XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults
Primary completion· ClinicalTrials.gov
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
Primary completion· ClinicalTrials.gov
A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity
Primary completion· ClinicalTrials.gov
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients
Trial registered· ClinicalTrials.gov
A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin
Primary completion· ClinicalTrials.gov
A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin
2023
Trial started· ClinicalTrials.gov
A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin
Trial registered· ClinicalTrials.gov
A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity
Trial started· ClinicalTrials.gov
A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity
Trial registered· ClinicalTrials.gov
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients
Trial registered· ClinicalTrials.gov
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
Trial started· ClinicalTrials.gov
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
2022
Trial started· ClinicalTrials.gov
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients
Primary completion· ClinicalTrials.gov
Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
Trial started· ClinicalTrials.gov
XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults
Trial registered· ClinicalTrials.gov
XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults
2021
Trial started· ClinicalTrials.gov
Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
Trial registered· ClinicalTrials.gov
Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
Sources
FDA approvals, label revisions, and recalls come from the public openFDA APIs (Drugs@FDA, Drug Label, Drug Enforcement). Drug-safety communications come from the FDA RSS feed. Trial milestones come from ClinicalTrials.gov via the AACT pg dump. Pivotal-publication events come from PubMed, filtered to high-impact journals linked to a Phase 3 trial in our inventory.